相关实验视频

Updated: Jun 25, 2026

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

5.5K

开发和描述一种抗EphA2-CD11b双特异抗体的瘤向效率

Peggy A Birikorang1,2, Dominic M Menendez1,2, Robert Edinger3

  • 1Department of Biochemistry, University of Missouri-Columbia, 503 S College Avenue, Columbia, Missouri 65211, United States.

Bioconjugate chemistry
|May 28, 2025
PubMed
概括

这项研究开发了一种针对EphA2和CD11b的双特异抗体,用于癌症治疗. 通过活动或阻断策略进行优化是必要的,以增强放射性免疫结合物的瘤向.

更多相关视频

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

3.8K
Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells10:19

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Published on: May 12, 2023

1.3K

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...